Manufacturing

Pharma

Teva leans on Ajovy and Austedo as revenues sink

Teva's new CEO Richard Francis has his work cut out as the company seeks to recover from a revenue slide.
Zoey Becker Feb 8, 2023 2:55pm

Vertex teases launch plans for first CRISPR gene editing therapy

Feb 8, 2023 2:55pm

Daiichi Sankyo is setting up Japan's first mRNA plant

Feb 7, 2023 10:43am

Catalent reports weaker earnings, stronger ties with Moderna

Feb 7, 2023 9:40am

Catalent draws buyout interest from Danaher: Bloomberg

Feb 6, 2023 11:24am

Teva walks away from PhRMA after similar move by AbbVie

Feb 3, 2023 4:05pm